BioNTech SE (BNTXN.MX)
Develops messenger RNA vaccines and cancer treatments using genetic technology.
1,590.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-22.4%
The outlook
BioNTech is trading near 1590 and sits well below both its 50- and 200-day moving averages, indicating downward momentum. The stock sits in the lower portion of its 52-week range, roughly 21% up from its yearly low. Analyst sentiment currently leans bearish overall.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range21% of the way from its 52-week low to high
Market cap
$402.09B
52-wk high
2,100.00
52-wk low
1,456.73
50-day avg
1,600.64
200-day avg
1,726.54
Trailing P/E
—